A global community of more than 18,000 scientists, technologists, researchers, academics and data informatics professionals. SLAS is a global community of more than 18,000 scientists—from academia, government and industry—collectively focused on leveraging the power of technology to achieve scientific objectives. We consider a primary part of our mission to unite great minds in science and technology for the advancement of all research.
The Evolution of a New Generation of Scientific Thought Leaders
In early 2009, the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA) began discussing ways the organizations could work together to further their respective and similar missions. These discussions led SBS and ALA to recognize that coordinating programs and activities offered many significant advantages. Accordingly, SBS and ALA assigned a task force of eight experienced volunteer leaders, four from SBS and four from ALA, to explore options and determine the viability of an SBS-ALA amalgamation and, if viable, to define its appropriate structure. The task force unanimously concluded that both SBS and ALA could be strengthened by merging into a new entity that advanced their common missions and goals while respecting and protecting the unique individual histories and identities of SBS and ALA.
Rationale (1 + 1 = 3)
Members of the SBS and ALA Boards of Directors agreed that merging the organizations would significantly advance the organizations' respective goals and, thereby, benefit individual members of both organizations and the public at large, expanding opportunities and strength by:
- Embracing and building shared goals and priorities
- Expanding organizational scope and global influence
- Elevating the quality and significance of annual conferences and exhibitions
- Enhancing the reach, impact and efficiency of promotional opportunities for exhibitors and sponsors
- Streamlining operational costs and increasing administrative efficiencies
- Creating a sound financial foundation for organizational maintenance and growth
As part of SBS and ALA's investigation regarding the viability of consolidation, each organization conducted a thorough due diligence review of the other. Following the completion of these reviews, both organizations agreed that the idea of a merger was both viable and attractive. After that, a formal Plan and Agreement of Merger was developed outlining the terms and conditions of such a merger for consideration by the boards of directors of both organizations.
Agreement and Recommendation
In January 2010, comprehensive plans were presented and discussed by both boards of directors. After the boards of directors provided input and made revisions, a final Plan and Agreement of Merger was adopted by both boards via separate resolutions with recommendations that the plan be presented to the SBS and ALA memberships for a vote.
As of May 5, 2010, both memberships officially authorized the merger with more than 95% of the votes cast in favor of the plan. The inspectors for the proxy voting process reported that SBS and ALA exceeded quorum requirements by 124% and 218%, respectively, and certified the results as valid. The SBS Inspector was the law firm of Pillsbury Winthrop Shaw Pittman of Washington, DC. The ALA Inspector was the law firm of Gaido & Fintzen of Chicago, IL.
About the Name
The name Society for Laboratory Automation and Screening (SLAS) is inspired by its origins: the union of two respected and established organizations, the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA).
SLAS serves a global community of life sciences research and development (R &D) professionals from academia, government and industry through education, information and unique access. SLAS provides the gateway for these scientists, researchers, engineers and technology providers to stay on top of innovative breakthroughs in scientific technology, and to work together to achieve objectives for themselves, their organizations and the industry as a whole.
Our corporate tagline, Come Transform Research,conveys the SLAS brand essence as a mission-driven organization that unites a global community dedicated to advancing science and research through the use of technology.
SLAS is an Illinois not-for-profit corporation formed on January 12, 2010. It is organized and operated exclusively for charitable, educational, and scientific purposes as defined by Internal Revenue Code Section ('IRC') 501(c) (3). In particular, SLAS's exempt purpose is to advance laboratory science and technology through education, scientific research, and to serve as a public forum for the exchange of information related to laboratory science and technology.
SLAS is a global organization that exists to provide forums for education and information exchange to encourage the study of, and improve the science and practice of, laboratory automation and screening.
- Biomolecular Sciences Section
To advance SLAS's exempt purposes with respect to the science and technology of drug discovery and the use and development of biomolecular screening technology.
- Laboratory Automation Section
To advance SLAS's exempt purpose by furthering science and education related to laboratory automation, and in particular by encouraging and advancing the study and improving the practice of laboratory automation.
Tax Exempt Status
SLAS has been deemed a tax exempt organization under section 501 (c) (3) of the United States Internal Revenue Code. Contributions or gifts to SLAS are tax deductible as charitable under section 170 of the Internal Revenue Code. SLAS is also qualified to receive tax deductible bequests, devisees, transfers or gifts under section 2055, 2106 or 2522 of the Code. A copy of the IRS letter verifying 501 (c) (3) status for SLAS can be found here.
SLAS believes it is important to make information about its operations, including its governance, finances, programs, and activities widely available to the public. Toward this